DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Information source: Novartis
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Influenza, Human

Intervention: Adjuvanted trivalent inactivated subunit influenza vaccine (Biological); Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccine (Biological); Meningococcal C conjugate vaccine or tick-borne encephalitis vaccine (Biological)

Phase: Phase 3

Status: Completed

Sponsored by: Novartis

Official(s) and/or principal investigator(s):
Novartis Vacccines and Diagnostics, Study Director, Affiliation: Novartis

Summary

This study will evaluate the efficacy, safety and immunogenicity of one or two 0. 25 mL or 0. 5 mL intramuscular injections of an adjuvanted influenza vaccine compared with non-influenza and non-adjuvanted influenza control vaccines in subjects 6 to <72 months of age.

Clinical Details

Official title: A Phase III, Randomized, Observer-blind, Controlled, Multi-center Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of One and Two Intramuscular Doses of Influenza Vaccine Versus Control Vaccines in Healthy Subject Aged 6 to <72 Months

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Primary outcome:

Number of Subjects (Unprimed) 6 to <36 Months Age With Local and Systemic Reactions After Any Vaccination for All Seasons, Comparison of Adjuvanted Trivalent Influenza Vaccine (aTIV) and Flu Vaccine Control

Percentage of Subjects (Unprimed) Aged 6 to <36 Months With Virus-Confirmed Influenza, Comparison of aTIV and Non-flu Vaccine Control (Men C/TBE Vaccine)

Secondary outcome:

Number of Subjects (Unprimed) of 6 to <72 Months Age With Local and Systemic Reactions After Any Vaccination

Number of Subjects (Unprimed) With Unsolicited Adverse Events Reported After Any Vaccination

Percentage of Subjects (Unprimed) Aged 6 to <72 Months With Virus-Confirmed Influenza, Comparison of aTIV to Non-flu Vaccine Control and Flu-vaccine Control (Matched Strains)

Percentage of Subjects (Unprimed) Aged 6 to <72 Months With Virus-Confirmed Influenza, Comparison of aTIV to Non-flu Vaccine Control and Flu Vaccine Control (Any Strains).

Number of Subjects (Unprimed) With Influenza Like Illnesses (ILIs) in the 6 to <72 Months Age Cohort for Combined Seasons 2007/08 and 2008/09

Number of Subjects With Influenza Like Illnesses (ILIs) in the 6 to <36 Months and in Overall Age Cohort (Unprimed Subjects Aged 6 to <72 Months) for Combined Seasons 2007/08 and 2008/09

Loss of Days of Usual Activity (Job, School, Day Care, Household/Family/Community Activities) Due to Influenza Like Illness (ILI) in Subjects in Aged 6 to <72 and 6 to <36 Months and in Direct Caregivers Living in the Household.

Number of Events of Influenza Like Illness for Combined Seasons 2007/08 and 2008/09.

Immunogenicity of aTIV, Compared to Flu and Non-Flu-control, in Terms of GMRs, in Unprimed Subjects Aged 6 to <36 Months or Season 2008/09 (Homologous and Heterologous Strains)

Immunogenicity of aTIV, Compared to Flu and Non-Flu-control, in Terms of Geometric Mean Titers (GMTs), in Unprimed Subjects Aged 6 to <36 Months for Season 2008/09 (Homologous and Heterologous Strains)

Percentage (95% CI) of Unprimed Subjects Aged 6 to <36 Months With HI Titer ≥1:40 in Season 2008/09 HI Assay(Homologous and Heterologous Strains)

Percentage (95% CI) of Unprimed Subjects Aged 6 to <36 Months With Seroconversion From Baseline, for Season 2008/09 (Homologous and Heterologous Strains)

Immunogenicity of aTIV, Compared to Flu and Non-Flu-control, in Terms of GMTs, in Unprimed Subjects Aged 6 to <72 Months for Season 2008/09 (Homologous and Heterologous Strains)

Immunogenicity of aTIV, Compared to Flu and Non-Flu-control, in Terms of GMRs, in Unprimed Subjects Aged 6 to <72 Months for Season 2008/09 (Homologous and Heterologous Strains)

Percentages of Subjects With HI Titers ≥ 1:40 in Unprimed Subjects 6 to <72 Months of Age for Season 2008/09 Homologous and Heterologous Strains

Percentages of Subjects With Seroconversion and Vaccine Group Differences in Unprimed Subjects 6 to <72 Months of Age for Season 2008/09 (Homologous and Heterologous Strains)

Number of Subjects With Local and Systemic Reactions for Egg and Cell Derived Inactivated Novel Swine Origin A/H1N1 Subunit Influenza Vaccines After Each Vaccination for All Seasons

Indirect Protective Effect of Fluad (NH Composition 2007/2008), Compared to Non-flu Control and Flu Control, in Connection to Household-contact Persons Via a Questioning of the Parents About ILI of Persons Living in the Same Household as the Study Child

Incidence Rate of the 2009-2010 H1N1 Swine Pandemic Caused by a Novel Influenza A (H1N1) Virus of Swine Origin in Unprimed Children Aged 6 to <36 and 6 to <72 Months

Eligibility

Minimum age: 6 Months. Maximum age: 71 Months. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Children whose parents/legal guardians have given written informed consent prior to

study entry: a) aged 6 to <72 months (Part I and II of the study; influenza seasons 2007/2008 and 2008/2009) b) aged 6 to <36 months (Part III of the study; influenza season 2009/2010)

- In good health as determined by: a) medical history, b) physical examination, c)

clinical judgment of the investigator Exclusion criteria:

- Administration of licensed vaccines (including H1N1sw vaccines) within 14 days (for

inactivated vaccines) or 28 days (for live vaccines) prior to enrollment in this study. Routine vaccines, according to local recommendations, or any other vaccines not foreseen in the protocol could be given after the active trial phase (i. e., 21 days after last vaccination) has been concluded.

- Receipt of another investigational vaccine or any investigational agent within 30

days prior to enrollment in the study or before completion of the safety follow-up period in another study, whichever is longer, and participation in another clinical trial during the present study.

- Experience of a severe acute infectious disease in the month prior to study start or

experience of a mild acute infection disease in the week prior the study start (untreated common cold is acceptable). The severity of the infectious disease occurred will be based on the investigator's judgment.

- Any severe acute respiratory disease and infection requiring systemic antibiotic or

antiviral therapy ongoing or resolved within 2 days prior to study start.

- Experience an axillary temperature equal to or greater than 37. 8°C (rectal

temperature equal to or greater than 38. 3°C) within the 2 days before enrollment.

- Any serious disease in the opinion of the investigator including, for example: a)

cancer, b) autoimmune disease (including rheumatoid arthritis under immunosuppressive therapy), c) insulin dependent diabetes mellitus, d) chronic pulmonary disease, asthma under inhalative therapy only is acceptable, e) acute or progressive hepatic disease, f) acute or progressive renal disease.

- Known or suspected impairment/alteration of immune function, for example, resulting

from: a) receipt of immunosuppressive therapy (corticosteroid - except topical or

inhaled steroids- or cancer chemotherapy), b) receipt of immunostimulants, c) receipt of parenteral immunoglobulin preparation, blood products, and/or plasma derivatives within the past 90 days and for the full length of the study, d) high risk for developing an immunocompromising disease (suspected or known HIV infection or HIV-related disease).

- Bleeding diathesis.

- History of hypersensitivity to any component of the study medication or chemically

related substances.

- History of any anaphylaxis, serious vaccine reactions, or allergy to eggs, egg

products or any other vaccine component.

- Laboratory confirmed influenza disease.

- History of neurological disorder or seizures (febrile seizures allowed).

- Received any influenza vaccine.

- Major surgery planned during the study period.

- Any condition which, in the opinion of the investigator, might interfere with the

evaluation of the study objectives, e. g., planned travel or relocation of residence that would interfere with completion of study.

Locations and Contacts

East Vantaa Clinic, East Vaanta 01300, Finland

Espoo Vaccine Research Clinic, Espoo 02100, Finland

Helsinki East Vaccine Research Clinic, Helsinki 00930, Finland

Helsinki South Vaccine Research Clinic, Helsinki 00100, Finland

Jarvenpaa Vaccine Research Clinic, Jarvenpaa 04400, Finland

Kokkola Vaccine Research Clinic, Kokkola 67100, Finland

Kotka Clinic, Kotka 48600, Finland

Kuopio Vaccine Clinic, Kuopio 70100, Finland

Kuopio Vaccine Research Clinic, Kuopio 70211, Finland

Lahti vaccine research Clinic, Lahti 15140, Finland

Oulu Vaccine Research Clini, Oulu 90200, Finland

Pori Vaccine Research Clinic, Pori 28100, Finland

Seinajoki Clinic, Seinajoki 60100, Finland

Tampere Vaccine Research Clinic, Tampere 33100, Finland

Turku Clinic, Turku 20520, Finland

Vantaa West Vaccine Research Clinic, Vantaa 01600, Finland

West Vantaa Clinic, West Vantaa 01600, Finland

Praxis Dr med Thilo Heising, Aalen Wasseralfingen 73433, Germany

"Praxis Dr med Dietrich Lasius", Berlin 13439, Germany

Praxis Dipl med Andreas Muhmer, Berlin 10559, Germany

Praxis Dipl. med. F. Temmler / Dipl. med. D. Wenzel, Berlin 12619, Germany

Praxis Dr Luise Schroeter, Berlin 13347, Germany

Praxis Dr med Dorothea Budde, Berlin 12209, Germany

Praxis Dr med Eva Brand, Berlin 12165, Germany

Praxis Dr med Klaus-Peter Falkowski, Berlin 10999, Germany

Praxis Dr med Mechthild Vocks-Hauck, Berlin 10627, Germany

Praxis Dr med Petra van Stiphout, Berlin 12679, Germany

Praxis Dr med Thomas Richter, Berlin 10551, Germany

Praxis Dr med Ursula Hornlein, Berlin 10315, Germany

Praxis Dr. med. Cornelia Busse, Berlin 12589, Germany

Praxis Dr. med. Petra Sandow, Berlin 14052, Germany

Praxis Dr Norbert Meister, Bindlach 95463, Germany

Praxis Dr med Thomas Tuschen, Binngen Rhein 55411, Germany

Praxis Dr. Elmar Dietmair, Bobingen 86399, Germany

Praxis Dr med Brigitta Becker, Bochum 44866, Germany

Praxis Karl-Heinz Blattel, Braunfels 35619, Germany

Praxis Dr. med. Roland Knecht, Bretten 75015, Germany

Praxis Dr. med. Maria R. Holtorf, Brunsbuettel 25541, Germany

Praxis Dr Klaus Helm, Detmold 32756, Germany

Praxis Joseph Zakarian, Duesseldorf 40223, Germany

Praxis Dr med Hans-Henning Peters, Eschwege 37269, Germany

Praxis Dr. med. Dirk Straub, Essen 45276, Germany

Peaxis Dr H Outzen jun, Flensburg 24943, Germany

Praxis Dr med Rainer Haase, Flensburg 24937, Germany

Praxis Dr. med. Per Gildberg, Flensburg 24937, Germany

Praxis Dr Lothar MaurerJun, Frankenthal 67227, Germany

Praxis Dr med Walter Otto, Fulda 36037, Germany

Praxis Dr med Hans-Joachim Buttner, Gau-Odernheim 55239, Germany

Praxis Dr med Christian Kayser, Gehrden 30989, Germany

Praxis Ute Jessat, Gluecksburg 24960, Germany

Praxis Dr. med. Dubravka Pock-Lutz, Grevenbroich 41515, Germany

Praxid Dr. med. Karl-Heinrich Hansen, Hamburg 22147, Germany

Praxis Dr Anna Halat, Hamburg 22149, Germany

Praxis Dr med Bernard Nast, Hamburg 22307, Germany

Praxis Dr. med. Malte Klarczyk, Hamburg 22089, Germany

Praxis Dr med Jurgen Schwalbe, Hameln 31785, Germany

Praxis Dr med Hans-Heinrich Rohe, Hille 32479, Germany

Praxis Dr Marlies Bolich, Jena 97745, Germany

Praxis Peter Bosch, Karlsruhe-Oberreut 76189, Germany

Praxis Dr Peter Andoko Soemantri, Kleve-Materborn 47533, Germany

Praxis Dr. Michael Muehlschlegel, Lauffen 74348, Germany

Praxis Dr Sibylle Hetzinger, Lobenstein 07356, Germany

Praxis Dipl med Dagmar Manegold-Randel, Lohne 32584, Germany

Praxis Dr. Renate Lang, Ludwigsburg 71634, Germany

Praxis Dr med Julika Kelber, Luneburg 21339, Germany

Johannes Gutenberg-University, Mainz 55101, Germany

Praxis Uwe Jakob, Mainz 55131, Germany

Praxis Dr med Falko Panzer, Mannheim 68167, Germany

Praxis Dr med Volker Tempel, Marbach a. N. 71672, Germany

Praxis Dr. med. Herbert Kollaschinski, Marktredwitz 95615, Germany

Praxis Dr med Matthias Donner, Moenchengladbach 41236, Germany

Praxis Ralph Koellges, Moenchengladbach 41236, Germany

Praxis Dr. med. Janina Joiko, Muenchen 81369, Germany

"Praxis Prof Dr med Stefan Walter Eber", Munchen 81377, Germany

Praxis Dr med Peter Dietl, Munchen 81475, Germany

Praxis Dr med Philip Fellner von Feldegg, Munster / NRW 48163, Germany

Praxis Dipl Med Ute Macholdt, Neuhaus am Rennweg 98724, Germany

Praxis Dr Rossius, Neumuenster 24534, Germany

Praxis Dr Sabine Maruschke, Neumuenster 24534, Germany

Praxis Drs J und K Kandzora, Neumuenster 24534, Germany

Praxis Dr. med. S. Mohns-Petersen, Niebuell 25899, Germany

Praxis Dr med Hartmut Scheele, Niedernhausen 65527, Germany

Praxis Dr med Stefan Noll, Porta Westfalica 32457, Germany

Praxis Zlatka Zochev Donkov, Rendsburg 24768, Germany

Praxis Dr med Michael Vomstein, Schwabisch Hall 74523, Germany

"Praxis Dr med Gunther Knapp", Schwieberdingen 71701, Germany

Praxis Thomas Morandini, Schönenberg 66901, Germany

Praxis Dr med Ulrich Soergel, Stadthagen 31655, Germany

Praxis Dr Ulrich Pfletschinger, Stuttgart 70469, Germany

Praxis Dr. med Heidi B. John-Wagenmann, Stuttgart 70619, Germany

Praxis Dr. med Manfred Heitz, Stuttgart 70499, Germany

Praxis Dr. med. Rolf Ebert, Tauberbischofsheim 97941, Germany

Praxis Dr med Karl-Eugen Mai, Tettnang 88069, Germany

Praxis Dr med Klaus Kindler, Trier 54290, Germany

Praxis Dr med Ralph Maier, Tuttlingen 78532, Germany

Praxis Dr med Ulrich Umpfenbach, Viersen 41751, Germany

Praxis Dr med Volker Kemmerich, Weinstadt 71384, Germany

Praxis Dr Per Bergmann, Winsen 29308, Germany

Praxis Dr med Steffi Bulst, Wurzen 04808, Germany

Fondazione IRCCS Policlinico Mangiagalli e Regina Elena, Milano 20122, Italy

Ospedale Maggiore della Carita, Novara 28100, Italy

Additional Information

Starting date: November 2007
Last updated: October 13, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017